|
LI-COR Biosciences Announces Environmental Education Fund Program for Undergraduate Institutions (SYS-CON Media)
LI-COR Biosciences is offering$500,000 in funding for colleges and universities through its LI-COREnvironmental Education Fund (LEEF). LEEF grants are to be used byfour-year undergraduate institutions to acquire LI-COR photosynthesissystems for use by undergraduate students studying biology, environmentalscience, and related fields. The LEEF program is part of LI-COR's ongoingcommitment to help
(Sep 6, 2006)
Amorfix achieves milestone in developing Alzheimer's test (Pharmaceutical Business Review)
Amorfix Life Sciences and the Ontario Genomics have demonstrated that Amorfixs Epitope Protection (EP) technology, is able to detect amyloid, an accumulation of protein aggregates, which are also formed in Alzheimers disease.
(Sep 7, 2006)
Innovations in Diagnostics: Next generation molecular and point-of-care diagnostics driving personalized healthcare (Pharmaceutical Business Review)
The global diagnostics market is undergoing radical change; novel technologies driven by miniaturization and advances in genomics will enhance the role of diagnostics in the healthcare market, allowing more tests to be performed at the point-of-care and facilitating the shift towards personalized medicine.
(Sep 7, 2006)
ExonHit Licenses Merck Rights to RNA Splicing Microarray Patent (PR Newswire via Yahoo! Finance)
ExonHit Therapeutics S.A. , a drug and diagnostic discovery company, today announces that Merck & Co., Inc. has been granted a non-exclusive license to rights for research only under Patent US 6,881,571.
(Sep 7, 2006)
Rosetta Genomics Ltd. Files for Initial Public Offering (PR Newswire via Yahoo! Finance)
Rosetta Genomics today announced that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its ordinary shares.
(Sep 7, 2006)
Wockhrdardt Hospitals, India - Fast Becoming A Preferred Destination for US Medical Tourists (PR Web)
A fall down a hill in Palo Duro Canyon began a year long journey for a Fairfield woman and end in a hospital in India where she became part of a growing trend called Medical Tourism. (PRWEB Sep 7, 2006)
(Sep 7, 2006)
Massively Parallel Technologies and the University of Colorado Enter Into Cooperative Relationship for Large-Scale (PR Web)
Combining innovative proteomics application with Massively Parallel Technologies’ high-performance software technology holds the potential to transform speed and accuracy of disease biomarker discovery. (PRWEB Sep 7, 2006) Trackback URI: http://www.prweb.com/zingpr.php/Q3Jhcy1UaGlyLVByb2YtTG92ZS1JbnNlLVplcm8=
(Sep 7, 2006)
Improvements in the Lab for Breast Cancer Screening (WKYT 27 NEWSFIRST & WYMT Mountain News)
(Ivanhoe Newswire) -- Labs full of beakers and pipettes may one day be replaced by a something as small as a nine-volt battery. New research may help to shrink the space needed in labs when it comes to doing cancer screenings.
(Sep 7, 2006)
ExonHit Licenses Merck Rights to RNA Splicing Microarray Patent (RedNova)
PARIS, France, September 6 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext : ALEHT), a drug and diagnostic discovery company, today announces that Merck & Co., Inc. has been granted a non-exclusive license to rights for research only under Patent US 6,881,571.
(Sep 7, 2006)
MDS Reports Third Quarter 2006 Financial Results (PR Newswire via Yahoo! Finance)
MDS Inc. , a company providing a range of enabling products and services to the global life sciences markets, today reported its third quarter 2006 results.
(Sep 7, 2006)
LSGPA Invests $250,000 in SoftGenetics, LLC (Business Wire via Yahoo! Finance)
STATE COLLEGE, Pa.----Sept. 7, 2006--The Life Sciences Greenhouse of Central Pennsylvania announced today an investment of $250,000 in SoftGenetics, LLC, a State College-based developer of software analysis tools for use by genetic researchers and diagnosticians.
(Sep 7, 2006)
Rescue of Nerve Cells in Neurodegenerative Diseases (uniprotokolle)
Dr. Robert Korneluk from the University of Ottawa, Canada, and his team have been able to show that the inhibition of an intricate control system to balance cell proliferation and cell death, called apoptosis or programmed cell death, can rescue the function of neurons in the central nervous system.
(Sep 7, 2006)
Massively Parallel Technologies and the University of Colorado Enter Into Cooperative Relationship for Large-Scale (PR Web via Yahoo! News)
LOUISVILLE, Colo. (PRWEB) September 7, 2006 -- Massively Parallel Technologies, Inc.
(Sep 7, 2006)
Partners HealthCare and Affymetrix Collaborate to Develop Microarray Diagnostics (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif. & BOSTON----Sept. 7, 2006--Affymetrix Inc. and Partners HealthCare announced today that they have entered into a three-year translational research collaboration to develop microarray-based diagnostics for complex diseases such as newborn hearing loss, autism and hypertrophic cardiomyopathy.
(Sep 7, 2006)
Strategic Diagnostics Announces New Agreement to Supply Diagnostic Antibody Reagents (Business Wire via Yahoo! Finance)
NEWARK, Del.----Sept. 7, 2006--Strategic Diagnostics Inc. today announced that it has signed a new agreement to supply bio-reagents to a large manufacturer of in-vitro diagnostics. The initial term of the agreement is five years.
(Sep 7, 2006)
Power3 Medical Products Chairman and CEO Steven B. Rash Featured on WallSt.net (Business Wire via Yahoo! Finance)
HOUSTON----Sept. 7, 2006--Steven B. Rash, the chairman and CEO of Power3 Medical Products, Inc. , is featured on the popular WallSt.net Web site , interviewed by Casey Rittenhouse, one of its editors.
(Sep 7, 2006)
Massively Parallel Technologies and the University of Colorado Enter Into Cooperative Relationship for Large-Scale (Press Release Network)
Massively Parallel Technologies, Inc. (Massively), a provider of on-demand high-performance computing (HPC), announces it has entered into a cooperative agreement with the University of Colorado for the development and commercialization of an innovative breakthrough in proteomics analysis. Working with Mark Duncan, Ph.D., professor at the University of Colorado at Denver and Health Sciences
(Sep 7, 2006)
Rosetta Genomics Sets IPO Price Range (AP via Yahoo! Finance)
Rosetta Genomics Ltd., a developer of diagnostic and therapeutic products that focus on cancer, on Thursday said it plans to sell 3 million shares in an initial public offering at $11 to $13 per share.
(Sep 7, 2006)
Cars back on Main Street (UB Reporter)
The visualization capabilities of UB's Center for Computational Research (CCR) are providing city residents with a multifaceted, interactive, real-time visualization of what activity on Main Street in the heart of downtown Buffalo would be like if vehicular traffic returns after an absence of more than 20 years.
(Sep 7, 2006)
Voice And Signature For The Identification Of Persons (Science Daily)
Some years ago the Department of Electronics and Telecommunications at the School of Engineering in Bilbao started joint work with a number of universities in Spain in order to design a database that would provide the biometric characteristics of hundreds of people. Currently, in order to complete the database, University of the Basque Country (UPV-EHU) researchers are focusing on analysing the
(Sep 7, 2006)
Variation In 3 Genes Influences Risk Of Age-related Macular Degeneration (Science Daily)
Researchers in Boston have discovered a new common, noncoding variant in the Complement Factor H (CFH) gene that is associated with age-related macular degeneration (AMD), the leading cause of irreversible visual impairment and blindness among persons aged 60 and older. Their analyses, for the first time, combine this new variant with all previously reported variants to estimate individual risk
(Sep 7, 2006)
Affymetrix will collaborate on diagnostics (bizjournals.com via Yahoo! Finance)
Affymetrix Inc. and the Partners HealthCare System said Thursday they signed a three-year agreement to collaborate on microarray-based diagnostics for complex diseases such as newborn hearing loss, autism and hypertrophic cardiomyopathy.
(Sep 7, 2006)
Genetic Engineering News Takes In-Depth Look at Molecular Diagnostics (Business Wire via Yahoo! Finance)
NEW ROCHELLE, N.Y.----Sept. 7, 2006--Genetic Engineering News highlights the rapidly growing and important field of molecular diagnostics with four articles focused on the topic in the September 1 issue.
(Sep 7, 2006)
Search Results (Terre Haute Journal of Business)
Domain name renewal and affordable web hosting packages from Network Solutions
(Sep 7, 2006)
Message Parse v3.18 – Email Processor Released by Cypress Technologies (PR Web)
A data extraction tool designed to capture information from email messages for use in other programs. (PRWEB Sep 7, 2006) Trackback URL: http://www.prweb.com/chachingpr.php/WmV0YS1UaGlyLVNpbmctWmV0YS1JbnNlLVplcm8=
(Sep 7, 2006)
Focusing in on Cancer’s Complexity (Howard Hughes Medical Institute)
In the first large-scale screen of genetic changes in cancer cells, researchers have found that a typical breast or colorectal tumor results from mutations in about 90 genes, with different sets of mutations producing the same type of cancer.
(Sep 7, 2006)
Methods for Analyzing High Dimensional Data for Classifying, Diagnosing, Prognosticating, and/or Predicting Diseases (Pharmalicencing)
This invention relates to a method of using supervised pattern recognition methods to classifying, diagnosing, predicting, or prognosticating various diseases.
(Sep 7, 2006)
Lumera Corporation to Present Poster and Exhibit at 12th Annual SBS Conference (Business Wire via Yahoo! Finance)
BOTHELL, Wash.----Sept. 7, 2006--Lumera Corporation , an emerging leader in the field of nanotechnology, announced today that Christina Boozer, Ph.D., Surface Scientist II, will be presenting a poster entitled "A New SPR Microarray Platform for Antibody Library Screening."
(Sep 7, 2006)
Genome code cracked for breast and colon cancers (EurekAlert!)
Johns Hopkins Kimmel Cancer Center scientists have completed the first draft of the genetic code for breast and colon cancers.
(Sep 7, 2006)
The Prairie Star (Prairie Star)
BELTSVILLE, Md. - A project involving Agricultural Research Service (ARS) and collaborating scientists could open the door to a new, genomics-based approach to identifying elite bulls.
(Sep 7, 2006)
Fox Chase researcher gets $11M cancer grant (Philadelphia Business Journal)
Fox Chase Cancer Center researcher V. Craig Jordan received a $10.7 million grant from the U.S. Department of Defense breast cancer research program to fund a breast cancer center of excellence at Fox Chase.
(Sep 7, 2006)
Genetic Engineering News Takes In-Depth Look at Molecular Diagnostics (RedNova)
Genetic Engineering News (GEN) highlights the rapidly growing and important field of molecular diagnostics with four articles focused on the topic in the September 1 issue.
(Sep 7, 2006)
Genome Code Cracked for Breast and Colon Cancers (Newswise)
Johns Hopkins Kimmel Cancer Center scientists have completed the first draft of the genetic code for breast and colon cancers. Their report, published online in the September 7 issue of Science Express, identifies close to 200 mutated genes, now linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control.
(Sep 7, 2006)
Unusual three-drug combo inhibits growth of aggressive tumors (EurekAlert!)
An experimental anti-cancer regimen combined a diuretic, a Parkinson's disease medication and a drug ordinarily used to reverse the effect of sedatives. The unusual mixture inhibited the growth of aggressive prostate tumors in laboratory mice in research conducted at Washington University School of Medicine in St. Louis.
(Sep 7, 2006)
Bio-Rad buys U.K. diagnostics business for $3M (bizjournals.com via Yahoo! Finance)
Hercules-based Bio-Rad Laboratories Inc. said Thursday it has purchased the medical diagnostics business of the U.K. health group Provalis PLC.
(Sep 7, 2006)
Scaffold Proteomics Data Mining Software Sold with Sage-N Sorcerer(TM) Systems for Low False Positive Protein ID Using (Business Wire via Yahoo! Finance)
SAN JOSE, Calif.----Sept. 7, 2006--Sage-N Research, Inc. signed an agreement to distribute the Scaffold proteomics data mining software from Proteome Software, primarily to use with Sorcerer Integrated Data Appliances .
(Sep 7, 2006)
Invitrogen Acquires Fluo 3 and Fluo 4 Product Lines (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----Sept. 7, 2006--Invitrogen Corporation , a leader in life science research, today announced it has completed an asset purchase of fluo 3 and fluo 4 product lines and all related intellectual property from TEF Labs Inc.
(Sep 7, 2006)
Illumina to Webcast Presentations at Two Financial Conferences in September (Business Wire via Yahoo! Finance)
SAN DIEGO----Sept. 7, 2006--Illumina, Inc. announced today that Jay Flatley, President and CEO, will be presenting at two upcoming financial conferences.
(Sep 7, 2006)
Genetic Secrets Of Human Egg Cracked By Scientists (Medical News Today)
The human egg's ability to transform into a new life, or into new cells that may someday save lives, is well documented. The mystery lies in the mechanics - in how a single cell can transform so nimbly.Scientists at Michigan State University report this week in the Proceedings of the National Academy of Sciences that they have identified genes unique to the human egg. [click link for full article]
(Sep 8, 2006)
TriMark Publications Announces Release of Its Over-the-Counter Diagnostic Products World Markets Report (PR Web via Yahoo! News)
New York, NY (PRWEB) September 8, 2006 -— TriMark Publications (http:
(Sep 8, 2006)
TriMark Publications Announces Release of Its Over-the-Counter Diagnostic Products World Markets Report (PR Web)
TriMark Publications, a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Over-the-Counter Diagnostic Products World Markets report. The purpose of this report is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. It examines the diagnostic measurement devices and their
(Sep 8, 2006)
Protagen Expands Its Board of Directors (Market Wire via Yahoo! Finance)
The Dortmund, Germany-based biotech company Protagen AG expands its board of directors from three to five members. In the last general meeting it was decided to enlarge the Board of Directors by two representatives of the investors of the last financing round.
(Sep 8, 2006)
Gene That Coordinates Two Cellular Processes Identified By NYU Biologists (Medical News Today)
A team of biologists at New York University's Center for Comparative Functional Genomics has uncovered a dual role for the gene mel-28. The gene plays a part in ensuring that chromosomes are divided properly during cell division and it is required for nuclear envelope function. The findings appear in the journal Current Biology. [click link for full article]
(Sep 8, 2006)
Molecular Chaperones Protect Cells - New Family Discovered (uniprotokolle)
Falsely folded proteins and their aggregations in neurons are considered to be the cause of neurodegenerative diseases, among them Chorea Huntington.
(Sep 8, 2006)
Stratagene Expands Rights to Molecular Diagnostics Intellectual Property Portfolio (Business Wire via Yahoo! Finance)
LA JOLLA, Calif.----Sept. 8, 2006--Stratagene Corporation , a developer, manufacturer and marketer of specialized life science research and diagnostic products, today announced that it has obtained an exclusive option to evaluate and license a family of patents and patent applications controlled by AROS Applied Biotechnology of Denmark.
(Sep 8, 2006)
Cyntellect LEAP(TM) System Receives CE Marking (PR Newswire via Yahoo! Finance)
Cyntellect, Inc., a privately-held biotechnology company based in San Diego, California, announced today that the Company's Laser-Enabled Analysis and Processing System is in conformance with the European Union's directives for CE marking.
(Sep 8, 2006)
Protagen Expands Its Board of Directors (SYS-CON Media)
The Dortmund,Germany-based biotech company Protagen AG expands its boardof directors from three to five members. In the last generalmeeting it was decided to enlarge the Board of Directors bytwo representatives of the investors of the last financinground. Professor Kleemann was reelected as Chairman of theBoard of Directors.
(Sep 8, 2006)
Software facilitates Linux cluster management. (ThomasNet)
Compatible with Rocks cluster software distribution technology, PGI Cluster Development Kit(TM) helps build and test programs that utilize Linux clusters. It includes PGI compilers and tools as well as software libraries and utilities specifically designed to facilitate cluster setup and deployment. All compilers and tools feature full native support for OpenMP parallel programming extensions and
(Sep 8, 2006)
Protagen Expands Its Board of Directors (SYS-CON Media)
The Dortmund,Germany-based biotech company Protagen AG expands its boardof directors from three to five members. In the last generalmeeting it was decided to enlarge the Board of Directors bytwo representatives of the investors of the last financinground. Professor Kleemann was reelected as Chairman of theBoard of Directors.
(Sep 8, 2006)
Bioinformatics Study Finds Dozens of Mutated Genes in Common Cancers (Bio-IT World)
September 08, 2006 | Previous genetic studies of cancer have concentrated on specific genes or on chromosomal regions. In the September 8, 2006, issue of Science , Howard Hughes Medical Institute (HHMI) investigators Bert Vogelstein at Johns Hopkins University and Sanford D. Markowitz at Case Western Reserve University School of Medicine, together with a team of researchers from The Kimmel Cancer
(Sep 8, 2006)
|
